Effect of Infraorbital and Infratrochlear Nerve Block on Emergence Agitation in Patients Undergoing Septorhinoplasty
NCT ID: NCT02751268
Last Updated: 2016-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
66 participants
INTERVENTIONAL
2016-04-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
placebo for the realization of infraorbital and infratrochlear block
Normal Saline
Bilateral infraorbital and infratrochlear nerve block before general anesthesia with normal saline
Ropivacaine
ropivacaine for the realization of infraorbital and infratrochlear block
Ropivacaine
Bilateral infraorbital and infratrochlear nerve block before general anesthesia with 0.5% ropivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normal Saline
Bilateral infraorbital and infratrochlear nerve block before general anesthesia with normal saline
Ropivacaine
Bilateral infraorbital and infratrochlear nerve block before general anesthesia with 0.5% ropivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) classification I-II
* Written informed consent
Exclusion Criteria
* Allergy to ropivacaine
* Incapability to give consent
* Chronic pain
* Coagulopathy
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Armed Forces Hampyeong Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hoon Choi
M.D. Department of Anesthesiology and Pain Medicine, Armed Forces Hampyeong Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hoon Choi, M.D.
Role: PRINCIPAL_INVESTIGATOR
Armed Forces Hampyeong Hostpital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Armed Forces Hampyeong Hospital
Geumgyeri, Haebo-myeon, Hampyeong-gun, Jeollanam-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim HJ, Kim DK, Kim HY, Kim JK, Choi SW. Risk factors of emergence agitation in adults undergoing general anesthesia for nasal surgery. Clin Exp Otorhinolaryngol. 2015 Mar;8(1):46-51. doi: 10.3342/ceo.2015.8.1.46. Epub 2015 Feb 3.
Boselli E, Bouvet L, Augris-Mathieu C, Begou G, Diot-Junique N, Rahali N, Vertu-Ciolino D, Gerard C, Pivot C, Disant F, Allaouchiche B. Infraorbital and infratrochlear nerve blocks combined with general anaesthesia for outpatient rhinoseptoplasty: A prospective randomised, double-blind, placebo-controlled study. Anaesth Crit Care Pain Med. 2016 Feb;35(1):31-36. doi: 10.1016/j.accpm.2015.09.002. Epub 2015 Nov 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AFMC-16028-IRB-16-021
Identifier Type: -
Identifier Source: org_study_id